Lung Adenocarcinoma Overview

Save information for later
Sign Up

Learn About Lung Adenocarcinoma

View Main Condition: Non-Small Cell Lung Cancer (NSCLC)

What is the definition of Lung Adenocarcinoma?
Lung adenocarcinoma is a cancer that occurs due to abnormal and uncontrolled cell growth in the lungs. It is a subtype of non-small cell lung cancer that is often diagnosed in an outer area of the lung. Early lung cancers may not be associated with any signs and symptoms. As the condition progresses, affected people can experience chest pain, a persistent cough, fatigue, coughing up blood, loss of appetite, unexplained weight loss, shortness of breath, and/or wheezing.
What are the alternative names for Lung Adenocarcinoma?
  • Lung adenocarcinoma
Who are the top Lung Adenocarcinoma Local Doctors?
Dr. Jerome W. Bentz
Family Medicine
Dr. Jerome W. Bentz
Family Medicine

Platte Community Memorial Hospital Inc

601 E 7th St, 
Platte, SD 
 (35.8 mi)
605-337-3364
Languages Spoken:
English, German
See accepted insurances
Accepting New Patients

Jerome Bentz is a Family Medicine provider in Platte, South Dakota. Dr. Bentz and is rated as an Experienced provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Familial Hypertension, and Glucocorticoid-Remediable Aldosteronism. Dr. Bentz is currently accepting new patients.

Dr. Michael P. Pietila
Pulmonary Medicine
Dr. Michael P. Pietila
Pulmonary Medicine

Yankton Medical Clinic PC

300 N 2nd St, Avera St Anthonys, 
Oneill, NE 
 (69.0 mi)
402-336-2611
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Pietila is a Pulmonary Medicine provider in Oneill, Nebraska. Dr. Pietila and is rated as an Advanced provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, ALK-Positive Non-Small Cell Lung Cancer, and Squamous Cell Lung Carcinoma. Dr. Pietila is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Dr. Anthony J. Hericks
Intensive Care Medicine | Pulmonary Medicine
Dr. Anthony J. Hericks
Intensive Care Medicine | Pulmonary Medicine

Avera Mckennan

801 E Sioux Ave, 
Pierre, SD 
 (87.9 mi)
605-322-6930
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Anthony Hericks is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Pierre, South Dakota. Dr. Hericks and is rated as an Advanced provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Excessive Daytime Sleepiness, Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Gastrostomy, and Bone Marrow Aspiration. Dr. Hericks is currently accepting new patients.

View All Doctors
What are the latest Lung Adenocarcinoma Clinical Trials?
A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy With or Without Radiation Therapy for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer
A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy With or Without Radiation Therapy for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer
Who is this study for: Patients with PD-L1-negative, advanced non-small cell lung cancer
Enrollment Status: Recruiting
Publish Date: February 26, 2025
Intervention Type: Other, Procedure, Biological, Radiation
Study Drugs: Carboplatin, Ipilimumab, Nab-paclitaxel, Nivolumab, Paclitaxel, Pembrolizumab, Pemetrexed
Study Phase: Phase 2/Phase 3

Summary: This phase II/III trial compares the addition of radiation therapy to the usual treatment (immunotherapy with or without chemotherapy) versus (vs.) usual treatment alone in treating patients with non-small cell lung cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or that has spread from where it first started (primary s...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 2 Randomized Study of the BER Inhibitor TRC102 in Combination With Standard Pemetrexed-Platinum-Radiation in Stage III Non-Squamous Non-Small Cell Lung Cancer
A Phase 2 Randomized Study of the BER Inhibitor TRC102 in Combination With Standard Pemetrexed-Platinum-Radiation in Stage III Non-Squamous Non-Small Cell Lung Cancer
Who is this study for: Patients with stage III non-squamous non-small cell lung cancer
Enrollment Status: Recruiting
Publish Date: February 26, 2025
Intervention Type: Drug, Procedure, Biological, Radiation
Study Drugs: Cisplatin, Durvalumab, Methoxyamine, Pemetrexed
Study Phase: Phase 2

Summary: This phase II trial tests whether TRC102 (methoxyamine hydrochloride) in combination usual care treatment comprised of pemetrexed, cisplatin or carboplatin, and radiation therapy followed by durvalumab works better than the usual care treatment alone to shrink tumors in patients with stage III non-squamous non-small cell lung cancer (NSCLC). TRC102 is in a class of drugs called antineoplastic agen...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center